| Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection ZA Rizvi, R Dalal, S Sadhu, A Binayke, J Dandotiya, Y Kumar, ... Elife 11, e73522, 2022 | 68 | 2022 |
| Omicron sub-lineage BA. 5 infection results in attenuated pathology in hACE2 transgenic mice ZA Rizvi, J Dandotiya, S Sadhu, R Khatri, J Singh, V Singh, N Adhikari, ... Communications Biology 6 (1), 935, 2023 | 17 | 2023 |
| IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation S Sadhu, R Dalal, J Dandotiya, A Binayke, V Singh, MR Tripathy, V Das, ... Nature Communications 14 (1), 4060, 2023 | 17 | 2023 |
| Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity R Thiruvengadam, ZA Rizvi, S Raghavan, DR Murugesan, M Gosain, ... European journal of medical research 28 (1), 421, 2023 | 11 | 2023 |
| Proinflammatory innate cytokines and distinct metabolomic signatures shape the T cell response in active COVID-19 A Binayke, A Zaheer, J Dandotiya, SK Gupta, S Mani, MR Tripathy, ... Vaccines 10 (10), 1762, 2022 | 10 | 2022 |
| A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant N Hingankar, S Deshpande, P Das, ZA Rizvi, CK Wibmer, P Mashilo, ... PLoS pathogens 18 (4), e1010465, 2022 | 10 | 2022 |
| A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern HA Parray, N Narayanan, S Garg, ZA Rizvi, T Shrivastava, S Kushwaha, ... PLoS Pathogens 18 (12), e1010994, 2022 | 9 | 2022 |
| Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry S Sadhu, J Dandotiya, R Dalal, R Khatri, AZ Mykytyn, A Batra, M Kaur, ... Antiviral research 220, 105743, 2023 | 8 | 2023 |
| RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2 J Meena, P Singhvi, S Srichandan, J Dandotiya, J Verma, M Singh, ... European Journal of Pharmaceutics and Biopharmaceutics 176, 43-53, 2022 | 8 | 2022 |
| SARS-CoV-2 and its variants, but not Omicron, induces thymic atrophy and impaired T cell development ZA Rizvi, S Sadhu, J Dandotiya, A Binyka, P Sharma, V Singh, V Das, ... bioRxiv, 2022.04. 07.487556, 2022 | 4 | 2022 |
| Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2 A Athavale, A Gaur, N Ahmed, A Subramaniam, J Dandotiya, S Raj, ... Vaccines 12 (12), 1396, 2024 | | 2024 |
| Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge A Binayke, A Zaheer, S Vishwakarma, P Sharma, J Dandotiya, ... Journal of Medical Virology 96 (8), e29877, 2024 | | 2024 |
| Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study A Sasi, J Dandotiya, J Kaushal, S Ganguly, A Binayke, KM Ambika, ... Vaccine 42 (10), 2722-2728, 2024 | | 2024 |
| Omicron Sub-Lineage BA. 5 Infection Causes Attenuated Pathology and Results in Robust Protection in Omicron Recovered hACE2 Transgenic Mice R ZA, N Adhikari, K Sharma, J Dandotiya, R Khatri, V Singh, V KV, ... | | 2022 |
| CoviWall, a whole-virion inactivated B. 1.617. 2, induces potent humoral and Th1 response in mice and the vaccine protects against B. 1.617. 2 (Delta) challenge in Syrian hamsters. J Dandotiya, N Adhikari, MR Tripathy, K Jakhar, S SONAR, DR Pati, ... Frontiers in Immunology 15, 1447962, 0 | | |
